Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.

Autor: Flamand, Claude^1,2 (AUTHOR) cflamand@pasteur-cayenne.fr, Alves Sarmento, Christelle¹ (AUTHOR), Enfissi, Antoine³ (AUTHOR), Bailly, Sarah¹ (AUTHOR), Beillard, Emmanuel⁴ (AUTHOR), Gaillet, Mélanie⁵ (AUTHOR), Michaud, Céline⁵ (AUTHOR), Servas, Véronique⁵ (AUTHOR), Clement, Nathalie⁶ (AUTHOR), Perilhou, Anaïs⁶ (AUTHOR), Carage, Thierry⁷ (AUTHOR), Musso, Didier^8,9 (AUTHOR), Carod, Jean-françois¹⁰ (AUTHOR), Eustache, Stéphanie¹ (AUTHOR), Tourbillon, Céline¹ (AUTHOR), Boizon, Elodie¹ (AUTHOR), James, Samantha¹ (AUTHOR), Djossou, Félix¹¹ (AUTHOR), Salje, Henrik^2,12,13 (AUTHOR), Cauchemez, Simon² (AUTHOR)

Publikováno v: PLoS Neglected Tropical Diseases. 11/12/2021, Vol. 15 Issue 11, p1-13. 13p.

Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020

Autor: Flamand, Claude, Alves Sarmento, Christelle, Enfissi, Antoine, Bailly, Sarah, Beillard, Emmanuel, Gaillet, Mélanie, Michaud, Céline, Servas, Véronique, Clement, Nathalie, Perilhou, Anaïs, Carage, Thierry, Musso, Didier, Carod, Jean-François, Eustache, Stéphanie, Tourbillon, Céline, Boizon, Elodie, James, Samantha, Djossou, Félix, Salje, Henrik, Cauchemez, Simon, Rousset, Dominique

Funder: National Research Agency
Funder: Regional Health Agency of French Guiana
Funder: Institut Pasteur Urgence COVID-19 fundraising
BACKGROUND: While Latin America has been heavily affected by the pandemic, only a few seroprevalence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::482e78c17da460878da31e4199dc8acf